Your browser doesn't support javascript.
loading
A multicentric study to evaluate the use of relative retention times in targeted proteomics.
Vialas, Vital; Colomé-Calls, Núria; Abian, Joaquín; Aloria, Kerman; Alvarez-Llamas, Gloria; Antúnez, Oreto; Arizmendi, Jesus M; Azkargorta, Mikel; Barceló-Batllori, Silvia; Barderas, María G; Blanco, Francisco; Casal, J Ignacio; Casas, Vanessa; de la Torre, Carolina; Chicano-Gálvez, Eduardo; Elortza, Felix; Espadas, Guadalupe; Estanyol, Josep M; Fernandez-Irigoyen, Joaquín; Fernandez-Puente, Patricia; Fidalgo, María José; Fuentes, Manuel; Gay, Marina; Gil, Concha; Hainard, Alexandre; Hernaez, Maria Luisa; Ibarrola, Nieves; Kopylov, Arthur T; Lario, Antonio; Lopez, Juan Antonio; López-Lucendo, María; Marcilla, Miguel; Marina-Ramírez, Anabel; Marko-Varga, Gyorgy; Martín, Luna; Mora, Maria I; Morato-López, Esperanza; Muñoz, Javier; Odena, Maria Antonia; de Oliveira, Eliandre; Orera, Irene; Ortea, Ignacio; Pasquarello, Carla; Ray, Kevin B; Rezeli, Melinda; Ruppen, Isabel; Sabidó, Eduard; Del Pino, Manuel M Sanchez; Sancho, Jaime; Santamaría, Enrique.
Afiliación
  • Vialas V; ProteoRed-ISCIII, Universidad Complutense de Madrid, Madrid 28040, Spain.
  • Colomé-Calls N; ProteoRed-ISCIII, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain.
  • Abian J; ProteoRed-ISCIII, Instituto de Investigaciones Biomédicas de Barcelona, IIBB-CSIC/IDIBAPS, Barcelona 08036, Spain.
  • Aloria K; Department of Biochemistry and Molecular Biology, University of the Basque Country-UPV/EHU, Leioa 48940, Spain.
  • Alvarez-Llamas G; ProteoRed-ISCIII, IIS Fundación Jimenez Diaz, Madrid, Spain.
  • Antúnez O; ProteoRed-ISCIII, SCSIE Universitat de Valencia, Burjassot 46100, Spain.
  • Arizmendi JM; ProteoRed-ISCIII, University of the Basque Country-UPV/EHU, Leioa 48940, Spain.
  • Azkargorta M; ProteoRed-ISCIII, CIC bioGUNE, Science and Technology Park of Bizkaia, Derio, Spain.
  • Barceló-Batllori S; ProteoRed-ISCIII, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Barderas MG; ProteoRed-ISCIII, Hospital Nacional de Parapléjicos-SESCAM, Toledo, Spain.
  • Blanco F; ProteoRed-ISCIII, INIBIC-CHUAC, A Coruña 15006, Spain.
  • Casal JI; ProteoRed-ISCIII, Centro de Investigaciones Biológicas-CSIC, Madrid 28040, Spain.
  • Casas V; ProteoRed-ISCIII, Instituto de Investigaciones Biomédicas de Barcelona, IIBB-CSIC/IDIBAPS, Barcelona 08036, Spain.
  • de la Torre C; ProteoRed-ISCIII, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Chicano-Gálvez E; ProteoRed-ISCIII, Maimonides Institute for Biomedical Research and Universidad de Córdoba, Córdoba 14004, Spain.
  • Elortza F; ProteoRed-ISCIII, CIC bioGUNE, Science and Technology Park of Bizkaia, Derio, Spain.
  • Espadas G; ProteoRed-ISCIII, Centre de Regulació Genòmica, Universitat Pompeu Fabra, Barcelona 08003, Spain.
  • Estanyol JM; ProteoRed-ISCIII, Scientific and Technological Centers (CCiTUB), University of Barcelona, Barcelona 08036, Spain.
  • Fernandez-Irigoyen J; ProteoRed-ISCIII, Navarrabiomed Biomedical Research Center-IdiSNa, Pamplona, Spain.
  • Fernandez-Puente P; ProteoRed-ISCIII, INIBIC-CHUAC, A Coruña 15006, Spain.
  • Fidalgo MJ; ProteoRed-ISCIII, Scientific and Technological Centers (CCiTUB), University of Barcelona, Barcelona 08036, Spain.
  • Fuentes M; ProteoRed-ISCIII, Cancer Research Center, University of Salamanca-CSIC, IBSAL, Salamanca 37007, Spain.
  • Gay M; ProteoRed-ISCIII, Institute for Research in Biomedicine (IRB Barcelona), Barcelona 08028, Spain.
  • Gil C; ProteoRed-ISCIII, Universidad Complutense de Madrid, Madrid 28040, Spain.
  • Hainard A; Proteomics Core Facility CMU, University of Geneva, Geneva, Switzerland.
  • Hernaez ML; ProteoRed-ISCIII, Universidad Complutense de Madrid, Madrid 28040, Spain.
  • Ibarrola N; ProteoRed-ISCIII, Cancer Research Center, University of Salamanca-CSIC, IBSAL, Salamanca 37007, Spain.
  • Kopylov AT; Orekhovich Institute of Biomedical Chemistry RAMS, Moscow 119121, Russian Federation.
  • Lario A; ProteoRed-ISCIII, IPBLN (CSIC), Armilla, Granada, Spain.
  • Lopez JA; ProteoRed-ISCIII, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid 28029, Spain.
  • López-Lucendo M; ProteoRed-ISCIII, Centro de Investigaciones Biológicas-CSIC, Madrid 28040, Spain.
  • Marcilla M; ProteoRed-ISCIII, Centro Nacional de Biotecnologia (CSIC), Madrid 28049, Spain.
  • Marina-Ramírez A; ProteoRed-ISCIII, CBM Severo Ochoa (CSIC-UAM), Madrid 28049, Spain.
  • Marko-Varga G; Centre of Excellence in Biological and Medical Mass spectrometry, Lund University, Lund, Sweden.
  • Martín L; ProteoRed-ISCIII, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain.
  • Mora MI; ProteoRed-ISCIII, CIMA, University of Navarra, Pamplona 31008, Spain.
  • Morato-López E; ProteoRed-ISCIII, CBM Severo Ochoa (CSIC-UAM), Madrid 28049, Spain.
  • Muñoz J; ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
  • Odena MA; ProteoRed-ISCIII, Barcelona Science Park, Barcelona 08028, Spain.
  • de Oliveira E; ProteoRed-ISCIII, Barcelona Science Park, Barcelona 08028, Spain.
  • Orera I; ProteoRed-ISCIII, Instituto Aragonés de Ciencias de la Salud, Zaragoza 50009, Spain.
  • Ortea I; ProteoRed-ISCIII, Maimonides Institute for Biomedical Research and Universidad de Córdoba, Córdoba 14004, Spain.
  • Pasquarello C; Proteomics Core Facility CMU, University of Geneva, Geneva, Switzerland.
  • Ray KB; MilliporeSigma, St. Louis, MO, USA.
  • Rezeli M; Centre of Excellence in Biological and Medical Mass spectrometry, Lund University, Lund, Sweden.
  • Ruppen I; ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
  • Sabidó E; ProteoRed-ISCIII, Centre de Regulació Genòmica, Universitat Pompeu Fabra, Barcelona 08003, Spain.
  • Del Pino MMS; Departament de Bioquímica i Biologia Molecular, Universitat de Valencia, Burjassot 46100, Spain.
  • Sancho J; ProteoRed-ISCIII, IPBLN (CSIC), Armilla, Granada, Spain.
  • Santamaría E; ProteoRed-ISCIII, Navarrabiomed Biomedical Research Center-IdiSNa, Pamplona, Spain.
J Proteomics ; 152: 138-149, 2017 01 30.
Article en En | MEDLINE | ID: mdl-27989941
Despite the maturity reached by targeted proteomic strategies, reliable and standardized protocols are urgently needed to enhance reproducibility among different laboratories and analytical platforms, facilitating a more widespread use in biomedical research. To achieve this goal, the use of dimensionless relative retention times (iRT), defined on the basis of peptide standard retention times (RT), has lately emerged as a powerful tool. The robustness, reproducibility and utility of this strategy were examined for the first time in a multicentric setting, involving 28 laboratories that included 24 of the Spanish network of proteomics laboratories (ProteoRed-ISCIII). According to the results obtained in this study, dimensionless retention time values (iRTs) demonstrated to be a useful tool for transferring and sharing peptide retention times across different chromatographic set-ups both intra- and inter-laboratories. iRT values also showed very low variability over long time periods. Furthermore, parallel quantitative analyses showed a high reproducibility despite the variety of experimental strategies used, either MRM (multiple reaction monitoring) or pseudoMRM, and the diversity of analytical platforms employed. BIOLOGICAL SIGNIFICANCE: From the very beginning of proteomics as an analytical science there has been a growing interest in developing standardized methods and experimental procedures in order to ensure the highest quality and reproducibility of the results. In this regard, the recent (2012) introduction of the dimensionless retention time concept has been a significant advance. In our multicentric (28 laboratories) study we explore the usefulness of this concept in the context of a targeted proteomics experiment, demonstrating that dimensionless retention time values is a useful tool for transferring and sharing peptide retention times across different chromatographic set-ups.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cromatografía Liquida / Proteómica / Investigación Biomédica Tipo de estudio: Clinical_trials Idioma: En Revista: J Proteomics Asunto de la revista: BIOQUIMICA Año: 2017 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cromatografía Liquida / Proteómica / Investigación Biomédica Tipo de estudio: Clinical_trials Idioma: En Revista: J Proteomics Asunto de la revista: BIOQUIMICA Año: 2017 Tipo del documento: Article País de afiliación: España